Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells

Eur J Neurosci. 2001 May;13(10):1861-72. doi: 10.1046/j.0953-816x.2001.01563.x.

Abstract

The present study elucidated the protective effect of beta-carbolines (harmaline, harmalol and harmine) against oxidative damage of brain mitochondria, synaptosomes and PC12 cells induced by either dopamine or 6-hydroxydopamine. Harmaline, harmalol and antioxidant enzymes (superoxide dismutase/SOD and catalase) decreased the alteration of mitochondrial swelling and membrane potential induced by 200 microM dopamine or 100 microM 6-hydroxydopamine. Deprenyl attenuated the dopamine-induced mitochondrial dysfunction but did not reduce the effect of 6-hydroxydopamine. While beta-carbolines inhibited the electron flow in mitochondria, they did not enhance the depressant effect of catecholamines. beta-Carbolines and antioxidant enzymes reversed the depression of synaptosomal Ca2+ uptake induced by 10 microM catecholamines. The compounds inhibited the catecholamine-induced thioredoxin reductase inhibition, thiol oxidation and carbonyl formation in mitochondria and synaptosomes. beta-Carbolines decreased the reactive species-induced deoxyribose degradation. Harmaline and harmalol reduced the catecholamine-induced loss of the transmembrane potential and of cell viability in PC12 cells. beta-Carbolines alone did not show a significant cytotoxic effect on PC12 cells. The results suggest that beta-carbolines may attenuate the dopamine- or 6-hydroxydopamine-induced alteration of brain mitochondrial and synaptosomal functions, and viability loss in PC12 cells, by a scavenging action on reactive oxygen species and inhibition of thiol oxidation.

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / pathology
  • Calcium / metabolism
  • Cell Survival / drug effects
  • Deoxyribose / metabolism
  • Dopamine / pharmacology*
  • Harmaline / analogs & derivatives
  • Harmaline / pharmacology*
  • Intracellular Membranes / metabolism
  • Mitochondria / drug effects
  • Mitochondria / pathology
  • Neurons / drug effects*
  • Neurons / physiology
  • Neuroprotective Agents / pharmacology*
  • Oxidation-Reduction
  • Oxidative Stress
  • Oxidopamine / pharmacology*
  • PC12 Cells / drug effects
  • PC12 Cells / physiology
  • Permeability / drug effects
  • Proteins / metabolism
  • Rats
  • Sulfhydryl Compounds / metabolism
  • Synaptosomes / drug effects
  • Synaptosomes / pathology
  • Thioredoxin-Disulfide Reductase / metabolism

Substances

  • Neuroprotective Agents
  • Proteins
  • Sulfhydryl Compounds
  • harmalol
  • Deoxyribose
  • Oxidopamine
  • Harmaline
  • Thioredoxin-Disulfide Reductase
  • Calcium
  • Dopamine